Maintenance of low disease activity and remission with etanercept–disease-modifying antirheumatic drug (DMARD) combination therapy compared with treatment with DMARDs alone in Latin American patients with active rheumatoid arthritis: Subset analysis of a randomized trial

BACKGROUND: Current guidelines on the treatment of rheumatoid arthritis (RA) recommend early therapy targeting the achievement of low disease activity (LDA) or clinical remission. Little published information is available on the success of this treatment strategy in Latin America. In a subset analys...

Full description

Saved in:
Bibliographic Details
Published in:Medicine (Baltimore)
Main Authors: Zerbini, Cristiano A.F., Abud-Mendoza, Carlos, Mendez-Patarroyo, Paul, De Angelo Andrade, Mauricio, Pedersen, Ron, Vlahos, Bonnie, Borlenghi, Cecilia Elena
Format: Artigo
Language:Inglês
Published: Wolters Kluwer Health 2018
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6133462/
https://ncbi.nlm.nih.gov/pubmed/30200078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000011989
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items